Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Gastrointestinal 2Sarcoma 1NET 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Neuroendocrine Tumors 34Pheochromocytoma 14Thyroid Neoplasms 11Pituitary Neoplasms 11Carcinoma, Neuroendocrine 10Adrenocortical Carcinoma 10Thyroid Cancer, Papillary 9Paraganglioma 8Sarcoma 7Adrenal Gland Neoplasms 7Small Cell Lung Carcinoma 6Neuroblastoma 6Cushing Syndrome 6Parathyroid Neoplasms 5Neoplasms 5Carcinoma, Medullary 5Carcinoid Tumor 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Osteosarcoma 4Multiple Endocrine Neoplasia Type 1 4Meningioma 4Insulinoma 4Cholangiocarcinoma 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Adenoma, Islet Cell 4Adenocarcinoma, Follicular 4Thyroid Carcinoma, Anaplastic 3

Interventions

repotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Respiratory Tract Diseases × Endocrine × 30 days × Clear all
NCT03093116 2026-05-27

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Adenocarcinoma, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Diseases, Colonic Neoplasms, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡